The best technological innovations are inspired by nature.
GlycoNet Investigator named to the Order of Canada
Dr. Lori West receives one of Canada’s highest honours to recognize her leadership in organ transplantation and donation.
GlycoNet alumnus on developing tools for chemical glycomics
GlycoNet alumnus on developing tools for chemical glycomics Past HQP shares how the Network helped him reach where he is at today By Ali Chou In 2012, Dr. Samy Cecioni left France, where he completed all his education, and decided to move to Canada for a post-doctoral position. Dr. Cecioni became a GlycoNet HQP when […]
Top 10 stories from GlycoNet in 2020
A year in review in glycomics innovations.
It’s not all gloom and doom: 2020 wrapped
It’s not all gloom and doom: 2020 wrapped There’s still room for bloom. Images from Revathi’s Instagram (@revanescent96). By Revathi Reddy 2020 was a year like no other, if only I had a dollar every time someone said this. Just when I thought that working in the lab and living life as a grad student […]
Trainee at GlycoNet: Olivia Liu
Trainee at GlycoNet: Olivia Liu Where do you work, what is your position and who is your advisor? I am currently a M.Sc. student in the Faculty of Medicine and Life Sciences at McGill University, working in the lab of Dr. Bastien Castagner. Tell us about the project you’re working on. My project aims to […]
GlycoNet Start-up PanTHERA CryoSolutions receives up to $4 million US investment to advance technologies in regenerative medicine
The made-in-Canada technology is revolutionizing the cryopreservation of cell and tissues.
GlycoNet Scientific Director and PlantForm awarded grant to enable commercial-scale production of protein drugs
The NSERC Alliance Grant will support the advancement of glycoengineering technology for plant-derived proteins.
Dr. Warren Wakarchuk appointed Scientific Director of GlycoNet
The new Scientific Director will be responsible for leading GlycoNet’s scientific strategy and the Network’s global leadership in glycoscience.
Using plants to find new treatments for type 2 diabetes
GlycoNet researchers found more efficient ways to produce montbretin A, a potential anti-diabetes compound.